US FDA Doubts Hemp ‘Derivatives Created From Scratch’ Belong In Lawful Use Pathway
State ‘Popularity Contests’ Legalizing Cannabis Aren’t Good Model For FDA Hemp Regulation
States’ histories with legalizing cannabis aren’t good models for an hemp regulatory pathway, says FDA hemp and cannabis policy chief Norman Birenbaum. Influence from those models already seen in US with ingredients including delta-8 THC marketed as hemp as defined in federal law de-scheduling it as a controlled substance.
